The initial clinical results were announced of a continuous study for non-thermal Retina Regeneration Therapy (Ellex 2RT, Ellex Medical Lasers Ltd.). The results showed the therapy's potential to make improvements in and stabilize visual acuity, as well as reduce retinal edema in patients with diabetic maculopathy and macular edema without causing any damage to the photoreceptors.
The drug development pipeline is bursting with new pharmaceutical products that may one day be useful in glaucoma therapy.
Studies provide guidance on MMC use. Going back to the surface with refractive surgery. AMO unveils iLASIK vision correction, and much more.
Keratoectasia can develop after surface ablation in eyes with forme fruste keratoconus (FFKC), and there do not appear to be any identifiable features as protecting against that event.
Topical dorzolamide (Trusopt, Merck) may offer hope for the treatment of macular edema in some patients with retinitis pigmentosa and X-linked retinoschisis.
The incidence of dry eye has been increasing for more than a decade and will continue to do so as the percentage of the population over the age of 50 increases. The impact will be felt on patient quality of life as well as in financial costs directly and indirectly attributable to dry eye, making it all the more urgent for clinicians to become adept at managing this condition.
A proprietary tear-testing platform capable of measuring highly sensitive and specific biomarkers related to ocular physiology, is being developed by an in-vitro diagnostics company (TearLab, OcuSense).
Creation of a pocket for intracorneal riboflavin instillation using the femtosecond laser (IntraLase, Advanced Medical Optics) appears to be a safe and effective method for assisting cornea collagen cross-linking.
Congratulations to Dr Maria Joao Marques from Portugal, winner of Oertli Instruments' CO-MICS competition.
Spectral domain optical coherence tomography (SD-OCT), the latest generation of the technology, is a breakthrough because it has dramatically cut the time required to obtain images by eliminating the moving mirror that was a component of standard OCT.
Demand for excellent uncorrected distance visual acuity after cataract surgery is increasing, especially with the availability of new presbyopia-correcting IOLs. This phenomenon is opening up a new class of patients to the benefits of laser vision correction.
Topical therapy to treat posterior segment disease is possible despite the limitations of the blood-retinal barrier.
Topography-guided LASIK, used with a comprehensive eye scanner (Pentacam, Oculus), has been very successful in minimizing severe corneal distortions and offers reliable registration in most cases.
The results of the PrONTO Study, an exploratory open-label trial, indicated that intravitreal injection of ranibizumab (Lucentis, Genentech) produces rapid improvements in visual acuity and findings on optical coherence tomography (OCT) in patients treated for neovascular age-related macular degeneration.
As the evolution in refractive surgery continues, surgeons can expect to see the journey continuing back to the surface—aided by new strategies to improve the outcomes of sub-Bowman's keratomileusis (SBK) and PRK.
VEGF Trap (Regeneron Pharmaceuticals) has been seen in two studies (CLEAR-IT AMD 1 and CLEAR-IT AMD 2) to be safe, bioefficacious, and tolerated in the eyes of patients with neovascular age-related macular degeneration.
Advanced Medical Optics (AMO) continues its commitment to the LASIK industry by reaching out to a generation of nearly 290 million people worldwide who want better everyday vision.
New extended delivery methods are under development and in the future should facilitate more effective administration of numerous types of ocular agents.
Results of retrospective studies of eyes undergoing surface ablation treatments at the Cole Eye Institute, Cleveland Clinic, Cleveland, OH, are suggesting an algorithm for using mitomycin-C (MMC) to prevent haze.
A review of November's product news
A review of this month's research news
A review of November's industry news
Preview of this year's AAO meeting in New Orleans, including city and dining guides and all the show information you will need.
When we launched Ophthalmology Times Europe (OTE) two years ago, our aim was always to provide a forum for ophthalmologists to communicate their knowledge, discoveries, experience and opinions. This aim has not changed. However, with the industry evolving at such a dramatic rate, it is difficult to convey the views and opinions of everyone who wants to be heard in our print publication. Help is at hand.
Circumferential viscodilation and tensioning of Schlemm's canal is a safe and effective surgical procedure for reducing intraocular pressure in adult patients with open-angle glaucoma.
Spectral (fourier domain) optical coherence tomography (SOCT) represents a significant development in the field of retinal imaging.
Advanced Medical Optics (AMO) has entered into a US patent license agreement with Carl Zeiss Meditec.
Alimera Sciences and pSivida have completed enrolment for the FAME (Fluocinolone Acetonide in diabetic Macular Edema) study of Medidur.
Randomized data from a large cohort of women with cardiovascular disease or at a high risk of it indicate that seven years of daily supplementation with folic acid, vitamin B6, and vitamin B12 may reduce the risk of age-related macular degeneration (AMD), according to William G. Christen, ScD, PhD.
Researchers have identified the gene responsible for binocular vision.